192 related articles for article (PubMed ID: 22809888)
1. Local delivery of pravastatin inhibits intimal formation in a mouse vein graft model.
Zhang L; Jin H; Huang J; Lu H; Guan Y; Chen X; Sun H
Can J Cardiol; 2012; 28(6):750-7. PubMed ID: 22809888
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin exerts favourable effects on neointimal formation in a mouse model of vein graft.
Zhang L; Lu H; Huang J; Guan Y; Sun H
Eur J Vasc Endovasc Surg; 2011 Sep; 42(3):393-9. PubMed ID: 21693384
[TBL] [Abstract][Full Text] [Related]
4. Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft.
Handa M; Li W; Morioka K; Takamori A; Yamada N; Ihaya A
J Vasc Surg; 2008 Dec; 48(6):1566-74. PubMed ID: 18848756
[TBL] [Abstract][Full Text] [Related]
5. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
6. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts.
Schachner T; Zou Y; Oberhuber A; Tzankov A; Mairinger T; Laufer G; Bonatti JO
Ann Thorac Surg; 2004 May; 77(5):1580-5. PubMed ID: 15111146
[TBL] [Abstract][Full Text] [Related]
7. Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts.
Schachner T; Zou Y; Oberhuber A; Mairinger T; Tzankov A; Laufer G; Ott H; Bonatti J
Eur J Cardiothorac Surg; 2004 Apr; 25(4):585-90. PubMed ID: 15037276
[TBL] [Abstract][Full Text] [Related]
8. Macrophage depletion reduces monocyte chemotactic protein-1 and transforming growth factor-beta1 in healing rat vein grafts.
Wolff RA; Tomas JJ; Hullett DA; Stark VE; van Rooijen N; Hoch JR
J Vasc Surg; 2004 Apr; 39(4):878-88. PubMed ID: 15071458
[TBL] [Abstract][Full Text] [Related]
9. Influence of ischemic injury on vein graft remodeling: role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation.
Sakaguchi T; Asai T; Belov D; Okada M; Pinsky DJ; Schmidt AM; Naka Y
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):129-37. PubMed ID: 15632834
[TBL] [Abstract][Full Text] [Related]
10. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
11. A novel mouse model of autologous venous graft intimal hyperplasia.
Diao Y; Xue J; Segal MS
J Surg Res; 2005 Jun; 126(1):106-13. PubMed ID: 15916983
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of topical application of 5-fluorouracil on intimal hyperplasia of vein graft].
Guo M; Zhang Y; Tian D; Wu X; Chen Z; Ma L; Zheng Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Aug; 23(8):940-6. PubMed ID: 19728611
[TBL] [Abstract][Full Text] [Related]
13. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model.
Zhang L; Hagen PO; Kisslo J; Peppel K; Freedman NJ
J Vasc Surg; 2002 Oct; 36(4):824-32. PubMed ID: 12368745
[TBL] [Abstract][Full Text] [Related]
14. Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.
Kodama A; Komori K; Hattori K; Yamanouchi D; Kajikuri J; Itoh T
J Vasc Surg; 2009 May; 49(5):1272-81. PubMed ID: 19233592
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.
Morisaki K; Shibata R; Takahashi N; Ouchi N; Maehara Y; Murohara T; Komori K
J Vasc Surg; 2011 Dec; 54(6):1753-9. PubMed ID: 21890304
[TBL] [Abstract][Full Text] [Related]
16. [Local applied slow-releasing rapamycin inhibits neointima hyperplasia in vein graft].
Zhang LF; Xiao F; Li J; Wang J; Shi ZH; Li CY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1706-9. PubMed ID: 16854327
[TBL] [Abstract][Full Text] [Related]
17. PPARĪ³ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
[TBL] [Abstract][Full Text] [Related]
18. Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half LIM domains 5 plays a key role for vein graft intimal hyperplasia.
Nakanishi K; Saito Y; Azuma N; Sasajima T
J Vasc Surg; 2013 Jan; 57(1):182-93, 193.e1-10. PubMed ID: 23127979
[TBL] [Abstract][Full Text] [Related]
19. Increased neointimal formation after surgical vein grafting in a murine model of type 2 diabetes.
Salzberg SP; Filsoufi F; Anyanwu A; von Harbou K; Karlof E; Carpentier A; Dansky HM; Adams DH
Circulation; 2006 Jul; 114(1 Suppl):I302-7. PubMed ID: 16820590
[TBL] [Abstract][Full Text] [Related]
20. Mouse model of venous bypass graft arteriosclerosis.
Zou Y; Dietrich H; Hu Y; Metzler B; Wick G; Xu Q
Am J Pathol; 1998 Oct; 153(4):1301-10. PubMed ID: 9777962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
